Australia's most trusted
source of pharma news
Thursday, 19 March 2026
Thursday, 19 March 2026
Subscribe
Login
Novo slapped with Warning Letter
The FDA has slapped Novo Nordisk with a Warning Letter for unreported semaglutide safety signals, including deaths, with the TGA 'considering the issues raised'.
Oncology-focused team launches
An Australian duo have joined forces to offer pharma and biotech a single, coordinated team to accelerate clinical trials
TODAY
20 drugs jostle for April PBS slots
Eight new drugs could make their first appearance on the PBS next month along with a first biosimilar and a raft of new indications
TODAY
World's top drug, by a loophole
This drug brought in a handsome haul last year and seemed to be holding a comfortable lead but was it a win on a technicality?
18 March
'Bad juju' crashes Aussie company
A delayed announcement of a trial discontinuation has wiped 90 per cent from this company's market cap
18 March
Arrotex inks cardio drug deal
Aussie duo aims to commercialise a new triplet combo therapy for hypertension in Australia and New Zealand as early as next year
17 March
Novo CEO taps Australia to lead
Before shaking hands with Danish Royalty, Novo CEO Mike Doustdar touted an 'Australian-made' solution to the obesity epidemic
17 March
Latest Jobs
Corporate Operations ManagerWarehouse AssistantCustomer Service RepresentativePractice ManagerRegulatory Affairs SpecialistAccount ManagerDirector of OperationsBusiness Development Manager | Community Care16 more...
Pharma in Focus Jobs
Sales & Customer Relations (7)
- Customer Service Representative - St Leonards
- Account Manager - Sydney
- Business Development Manager | Community Care - Queensland
- Pharmaceutical Sales Representative - Sydney
- Devices Account Manager - Sydney
- Customer Service Representative - Pemulwuy
- Customer Service Representative - St Leonards
Clinical & Medical, R&D (2)
- Senior Manager, Clinical Operations (Japan) - Tokyo, Japan
- Senior Clinical Project Manager - Tokyo, Japan
Regulatory, Pharmacovigilance & QA (6)
- Regulatory Affairs Specialist - Lane Cove
- Pharmacovigilance Associate - Sydney
- Regulatory Affairs Specialist - Glenorie
- Associate Director Regulatory Operations (Japan) - Tokyo, Japan
- Senior Manager, Regulatory Affairs Operations - Tokyo, Japan
- Regulatory & Quality Manager - Melbourne
Devices (1)
Executive Roles (4)
- Director of Operations - Melbourne
- Associate Director Regulatory Operations (Japan) - Tokyo, Japan
- Senior Manager, Clinical Operations (Japan) - Tokyo, Japan
- Senior Manager, Regulatory Affairs Operations - Tokyo, Japan
Other (9)
- Corporate Operations Manager - Sydney, NSW
- Warehouse Assistant - Macquarie Park
- Practice Manager - Sydney
- Senior Recruitment Consultant - Sydney
- Pharmacy Storeperson - Toongabbie
- Warehouse Assistant - Eight Mile Plains
- Materials Planner - North Ryde
- Procurement Specialist - New South Wales
- Finance & Administration Officer - Macquarie Park
Global high-flyer lands Aussie gig
Ex-J&J, Sanofi and Takeda exec appointed to drive international approvals and sales, expanding this product range to 10 countries
TODAY
Who's taken home an MA Award?
The industry body has recognised those showing capability, professionalism, and commitment to ethical practice
TODAY
Locals improve CAR T therapy
The TGA has approved trials for a CAR T-cell therapy targeting a different receptor, improving the safety profile of the treatment
18 March
PBAC lets slip reason for 'go-slow'
The PBAC has revealed why it is dragging its heels in recommending a much-in-demand class of drugs, instead aiming for a "slow roll-out"
18 March
Australia lines up for RNA first
US company hopes to secure approval for its lead product in Australia within the next 12 months, and in other major markets in 2027
18 March
Meet pharma's newest blockbuster
A still-growing dual inhibitor almost quadrupled annual sales to scream into blockbuster territory, and it's showing up in PBS reimbursements
17 March
Seqirus takes jab to private market
Just in time for the upcoming flu season, CSL Seqirus has won TGA approval for its influenza vaccine in a younger adult cohort
17 March
Novartis quizzes Aussies on MS
National survey lifts the lid on entrenched public misconceptions about the condition with some alarming findings taking their toll
17 March
CEO pay packet rockets by 75%
In his second year in the job, this big pharma CEO has hit the big league, with his compensation package soaring
16 March
12 drugs in PBS limbo pileup
Twelve drugs that secured a recommendation at the PBAC's November 2025 meeting have stalled in the PBS listing process
16 March
GSK tops Kosi fundraising peak
Industry rose to the challenge to help raise record funds for rare cancer by scaling Australia's tallest mountain
16 March
Dept seeks expansion for big drugs
The DoH has asked PBAC to expand two blockbuster drugs, moving them to the first line, after a sponsor was knocked back
16 March
$57M J&J drug under threat
The TGA has approved the first generic of this J&J PBS listed drug while a second generic brand circles a BioMarin's medicine
16 March Approvals Action
Minister wins blockbuster price cut case
Gilead has lost a court battle to protect three drugs earning $164 million a year from follow-on statutory price cuts
13 March